Press releases
Panaxia And Neuraxpharm: First Export Of Medical Cannabis Sublingual Tablets To France
The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry Both companies have previously issued their premium oils to patients in France PANAXIA Labs Israel Ltd (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical cannabis products in pharmaceutical quality, and Neuraxpharm…